Elite in Ulcerative Colitis

Dr. David T. Rubin

Family Medicine
1278 60th St, 
Brooklyn, NY 
Elite in Ulcerative Colitis
1278 60th St, 
Brooklyn, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Rubin is a primary care provider, practicing in Family Medicine in Brooklyn, New York. Dr. Rubin is rated as an Elite provider by MediFind in the treatment of Ulcerative Colitis. His top areas of expertise are Colitis, Viral Gastroenteritis, Ulcerative Colitis, Endoscopy, and Colonoscopy.

His clinical research consists of co-authoring 543 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 244 articles and participated in 7 clinical trials in the study of Ulcerative Colitis.

Specialties
Family Medicine
Licenses
Family Medicine in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

1278 60th St, Brooklyn, NY 11219
Other Locations
1312 38th St, Brooklyn, NY 11218

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Phase 4 Study Evaluating Real-World Use of CDPATH™, a Crohn's Disease Risk Prediction Tool
A Phase 4 Study Evaluating Real-World Use of CDPATH™, a Crohn's Disease Risk Prediction Tool
Enrollment Status: Active_not_recruiting
Publish Date: November 05, 2025
Intervention Type: Other
Study Phase: Phase 4
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
Efficacy and Safety of ALTB-168 in Patients With Moderate to Severe Active, Anti-TNF Alpha and/or Anti-integrin Refractory Ulcerative Colitis: a 26-week, Open-label, Multi-center, Phase II Proof of Principle Trial
Efficacy and Safety of ALTB-168 in Patients With Moderate to Severe Active, Anti-TNF Alpha and/or Anti-integrin Refractory Ulcerative Colitis: a 26-week, Open-label, Multi-center, Phase II Proof of Principle Trial
Enrollment Status: Terminated
Publish Date: January 05, 2024
Intervention Type: Biological
Study Phase: Phase 2
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
Open Label, Randomized, Multicenter, Comparative Effectiveness Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission in Patients With Crohn's Disease
Open Label, Randomized, Multicenter, Comparative Effectiveness Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission in Patients With Crohn's Disease
Enrollment Status: Completed
Publish Date: July 21, 2021
Intervention Type: Other
Study Phase: Not Applicable
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 4, Open-label, Multicenter, Prospective Study to Evaluate the Effect of Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission During a 12-Month, Long-term Maintenance Phase With 2.4g/Day MMX Mesalamine/Mesalazine Once Daily in Adult Subjects With Ulcerative Colitis
A Phase 4, Open-label, Multicenter, Prospective Study to Evaluate the Effect of Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission During a 12-Month, Long-term Maintenance Phase With 2.4g/Day MMX Mesalamine/Mesalazine Once Daily in Adult Subjects With Ulcerative Colitis
Enrollment Status: Completed
Publish Date: June 09, 2021
Intervention Type: Drug
Study Phase: Phase 4
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects With Moderate to Severe Ulcerative Colitis
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects With Moderate to Severe Ulcerative Colitis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Budesonide MMX® 9 mg Extended-release Tablets as Add-on Therapy in Patients With Active, Mild or Moderate Ulcerative Colitis Not Adequately Controlled on a Background Oral 5-ASA Regimen
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Budesonide MMX® 9 mg Extended-release Tablets as Add-on Therapy in Patients With Active, Mild or Moderate Ulcerative Colitis Not Adequately Controlled on a Background Oral 5-ASA Regimen
Enrollment Status: Completed
Publish Date: September 06, 2019
Intervention Type: Drug
Study Phase: Phase 3
Evaluating a Prediction Tool and Decision Aid for Patients With Crohn's Disease
Evaluating a Prediction Tool and Decision Aid for Patients With Crohn's Disease
Enrollment Status: Completed
Publish Date: February 07, 2019
Intervention Type: Behavioral
Study Phase: Not Applicable
View 9 Less Clinical Trials

543 Total Publications

Correction: ACG Clinical Guideline Ulcerative Colitis in Adults.
Correction: ACG Clinical Guideline Ulcerative Colitis in Adults.
Journal: The American journal of gastroenterology
Published: December 12, 2025
Similar Doctors
Advanced in Ulcerative Colitis
Dr. Ira Steinmetz
Family Medicine
Advanced in Ulcerative Colitis
Dr. Ira Steinmetz
Family Medicine

Ira M. Steinmetz M.D. PC

1975 E 13th St, 
Brooklyn, NY 
 (2.9 miles away)
718-339-7000
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ira Steinmetz is a primary care provider, practicing in Family Medicine in Brooklyn, New York. Dr. Steinmetz has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of Ulcerative Colitis. His top areas of expertise are Eosinophilic Colitis, Bronchitis, Nephrosclerosis, and Renovascular Hypertension.

Experienced in Ulcerative Colitis
Dr. Jeffrey A. Kurta
Family Medicine
Experienced in Ulcerative Colitis
Dr. Jeffrey A. Kurta
Family Medicine

North Shore Medical Group Of The Mount Sinai School Of Medicine

2965 Long Beach Rd, 
Oceanside, NY 
 (18.9 miles away)
516-593-8953
Languages Spoken:
English
See accepted insurances

Jeffrey Kurta is a primary care provider, practicing in Family Medicine in Oceanside, New York. Dr. Kurta is rated as an Advanced provider by MediFind in the treatment of Ulcerative Colitis. His top areas of expertise are High Cholesterol, Familial Combined Hyperlipidemia, Xanthoma, and Myositis.

Monte J. Nussbaum
Experienced in Ulcerative Colitis
Dr. Monte J. Nussbaum
Family Medicine
Experienced in Ulcerative Colitis
Dr. Monte J. Nussbaum
Family Medicine

Northwell Health Physician Partners Family Medicine And Endocrinology At Lynbrook

733 Sunrise Hwy, First Floor, 
Lynbrook, NY 
 (16.9 miles away)
516-593-3535
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Monte Nussbaum is a primary care provider, practicing in Family Medicine in Lynbrook, New York. Dr. Nussbaum is rated as an Advanced provider by MediFind in the treatment of Ulcerative Colitis. His top areas of expertise are Sitosterolemia, High Cholesterol, Hemorrhagic Proctocolitis, and Familial Hypertension.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rubin's expertise for a condition
ConditionClose
View All 18 Advanced Conditions
View All 154 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile